Dr. Babak Alex Vakili, MD

Dr. Vakili practices at Heart Vein And Vascular in Longwood, Florida.

Dr. Vakili's NPI, 1407877384, was assigned on July 23, 2006. Dr. Vakili graduated from Albert Einstein College of Medicine in 1995. Dr. Vakili holds Florida license ME84848.

Dr. Vakili's primary practice is Heart Vein and Vascular, at 2170 W Sr 434, Longwood, FL 32779. The practice phone is (407) 990-1921.

Dr. Vakili's primary practice is Heart Vein And Vascular in Longwood, Florida. Dr. Vakili is also affiliated with AdventHealth Orlando. The medical group on file is Heart Vein and Vascular. Dmand AI also links Dr. Vakili to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vakili practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Vakili's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Vakili is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Vakili is licensed in Florida.

Dmand AI lists leg revascularization and varicose vein treatment among the conditions Dr. Vakili treats.

CMS data shows 3,052 Medicare services from Dr. Vakili across 28 procedure codes in 2024, for 260 Medicare patients. Medicare paid $559,014 for them.

CMS counts 260 Medicare patients who saw Dr. Vakili in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vakili's median patient age at 68, with 51% women.

In 2024, Dr. Vakili wrote 1,953 Medicare Part D claims for 332 patients. 80% of them were for generic drugs. CMS names the drug for 1,713 of them, across 31 drugs with 11 or more claims each, at $440,698 in total drug cost. In 2023, CMS named 1,098 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Vakili for performance year 2024, reported individually. Dr. Vakili accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 121 procedures of varicose vein removal by Dr. Vakili, more than 86% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Vakili in 2009. The most frequent topics are Angioplasty, Balloon, Coronary, Hospital Mortality and Myocardial Infarction. Dr. Vakili has published most often in Am J Cardiol.

CMS Open Payments shows 551 general payments to Dr. Vakili from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 90% of the total. Novo Nordisk Inc paid the most, $121,062.

Dmand AI lists 2 awards for Dr. Vakili, most recently CMS Stage 1 EHR in 2013.

Dr. Vakili graduated from Albert Einstein College of Medicine in 1995. Dr. Vakili is a member of ACC and SCAI.

Dr. Vakili is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.